肝细胞肝癌的多学科协作组概念及其实践

被引：13

作者：

吕毅

张谞丰

机构：

[1] 西安交通大学医学院第一附属医院肝胆外科

来源：

中华肝脏外科手术学电子杂志 | 2013年 / 2卷 / 01期

基金：

国家自然科学基金重点项目;

关键词：

D O I：

暂无

中图分类号：

R735.7 [肝肿瘤];

学科分类号：

100112 [医学生物化学与分子生物学];

摘要：

<正>多学科协作组(multidisciplinary team,MDT)是由多个相关学科的医师组成相对固定的专家组,针对某种疾病进行定期的临床讨论会,每位专家从自身学科角度出发对该患者的诊断和治疗提出自己的意见,最终使患者获得最佳疗效的临床诊疗模式[1]。MDT为医疗模式的转变带来了新思路,旨在使传统的个体经验性医疗模式转变为现代的小组协

引用

页码：1 / 3

页数：3

共 13 条

[1]

合并门静脉癌栓的原发性肝癌的手术治疗及预后分析 [J].

吕毅 ;

韩冰 ;

于良 ;

刘昌 ;

袁博 ;

潘承恩 .

现代肿瘤医学, 2007, (12) :1814-1816

[2]

肝癌肝移植适应证的选择:上海复旦标准 [J].

樊嘉 ;

周俭 ;

徐泱 ;

邱双健 ;

吴志全 ;

余耀 ;

黄晓武 ;

汤钊猷 ;

王玉琦 .

中华医学杂志, 2006, (18) :1227-1231

[3]

Clinicopathologic Characteristics and Surgical Outcomes of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis [J].

Chen, Jing-Song ;

Wang, Qian ;

Chen, Xi-Lin ;

Huang, Xiao-Hui ;

Liang, Li-Jian ;

Lei, Jian ;

Huang, Jiong-Qiang ;

Li, Dong-Ming ;

Cheng, Zhi-Xiang .

JOURNAL OF SURGICAL RESEARCH, 2012, 175 (02) :243-250

[4]

Spontaneous tumor rupture and surgical prognosis of patients with hepatocellular carcinoma [J].

Zhang, Xu-Feng ;

Wei, Tao ;

Liu, Xue-Min ;

Lv, Yi .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (8-9) :968-974

[5]

Multidisciplinary Management of Hepatocellular Carcinoma [J].

Guy, Jennifer ;

Kelley, Robin K. ;

Roberts, John ;

Kerlan, Robert ;

Yao, Francis ;

Terrault, Norah .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (04) :354-362

[6]

Treatment Strategy for Hepatocellular Carcinoma with Major Portal Vein or Inferior Vena Cava Invasion: A Single Institution Experience [J].

Yoshidome, Hiroyuki ;

Takeuchi, Dan ;

Kimura, Fumio ;

Shimizu, Hiroaki ;

Ohtsuka, Masayuki ;

Kato, Atsushi ;

Furukawa, Katsunori ;

Yoshitomi, Hideyuki ;

Miyazaki, Masaru .

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2011, 212 (05) :796-803

[7]

Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: Comparison of five staging systems [J].

Zhang, X. -F. ;

Qi, X. ;

Meng, B. ;

Liu, C. ;

Yu, L. ;

Wang, B. ;

Lv, Y. .

EJSO, 2010, 36 (08) :718-724

[8]

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial [J].

Cheng, Ann-Lii ;

Kang, Yoon-Koo ;

Chen, Zhendong ;

Tsao, Chao-Jung ;

Qin, Shukui ;

Kim, Jun Suk ;

Luo, Rongcheng ;

Feng, Jifeng ;

Ye, Shenglong ;

Yang, Tsai-Sheng ;

Xu, Jianming ;

Sun, Yan ;

Liang, Houjie ;

Liu, Jiwei ;

Wang, Jiejun ;

Tak, Won Young ;

Pan, Hongming ;

Burock, Karin ;

Zou, Jessie ;

Voliotis, Dimitris ;

Guan, Zhongzhen .

LANCET ONCOLOGY, 2009, 10 (01) :25-34

[9]

Neurogenic Tumors of the Pelvis: Clinicopathologic Features and Surgical Outcomes Using a Multidisciplinary Team [J].

Dozois, Eric J. ;

Wall, Jarrod C. H. ;

Spinner, Robert J. ;

Jacofsky, David J. ;

Yaszemski, Michael J. ;

Sim, Franklin H. ;

Moran, Steven L. ;

Cima, Robert R. ;

Larson, Dirk R. ;

Haddock, Michael G. ;

Okuno, Scott H. ;

Larson, David W. .

ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (04) :1010-1016

[10]

Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma [J].

Katz, Matthew H. G. ;

Wang, Huamin ;

Fleming, Jason B. ;

Sun, Charlotte C. ;

Hwang, Rosa F. ;

Wolff, Robert A. ;

Varadhachary, Gauri ;

Abbruzzese, James L. ;

Crane, Christopher H. ;

Krishnan, Sunil ;

Vauthey, Jean-Nicolas ;

Abdalla, Eddie K. ;

Lee, Jeffrey E. ;

Pisters, Peter W. T. ;

Evans, Douglas B. .

ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (04) :836-847

← 1 2 →